Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H15NO4 |
Molecular Weight | 309.316 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(O)C2=C(C=CC=C2)C(O)=C1OC(=O)C3=CC=C(N)C=C3
InChI
InChIKey=YLMPBJUYFTWHKJ-UHFFFAOYSA-N
InChI=1S/C18H15NO4/c1-10-15(20)13-4-2-3-5-14(13)16(21)17(10)23-18(22)11-6-8-12(19)9-7-11/h2-9,20-21H,19H2,1H3
Molecular Formula | C18H15NO4 |
Molecular Weight | 309.316 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Aminaphtone, a synthetic molecule derived from 4-aminobenzoic acid, is a drug affecting vessel functioning. Aminaphtone significantly protects endothelium permeability and stabilises endothelial cells organised in capillary-like structures, modulating VE-cadherin expression. In addition aminaphtone modulate expression of several inflammatory and vasoactive factors. Aminaphtone (Capilarema) is used in the treatment of vascular disorders, especially chronic venous disease.
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27083548
ECV-304 endothelial cells were stimulated with IL-1β 100U/ml in the presence or absence of Aminaphtone 6 μg/ml
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:02:46 GMT 2023
by
admin
on
Fri Dec 15 19:02:46 GMT 2023
|
Record UNII |
03JLX11PE9
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID00163725
Created by
admin on Fri Dec 15 19:02:46 GMT 2023 , Edited by admin on Fri Dec 15 19:02:46 GMT 2023
|
PRIMARY | |||
|
SUB12847MIG
Created by
admin on Fri Dec 15 19:02:46 GMT 2023 , Edited by admin on Fri Dec 15 19:02:46 GMT 2023
|
PRIMARY | |||
|
238-809-8
Created by
admin on Fri Dec 15 19:02:46 GMT 2023 , Edited by admin on Fri Dec 15 19:02:46 GMT 2023
|
PRIMARY | |||
|
14748-94-8
Created by
admin on Fri Dec 15 19:02:46 GMT 2023 , Edited by admin on Fri Dec 15 19:02:46 GMT 2023
|
PRIMARY | |||
|
46276
Created by
admin on Fri Dec 15 19:02:46 GMT 2023 , Edited by admin on Fri Dec 15 19:02:46 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000077685
Created by
admin on Fri Dec 15 19:02:46 GMT 2023 , Edited by admin on Fri Dec 15 19:02:46 GMT 2023
|
PRIMARY | |||
|
03JLX11PE9
Created by
admin on Fri Dec 15 19:02:46 GMT 2023 , Edited by admin on Fri Dec 15 19:02:46 GMT 2023
|
PRIMARY | |||
|
DB13039
Created by
admin on Fri Dec 15 19:02:46 GMT 2023 , Edited by admin on Fri Dec 15 19:02:46 GMT 2023
|
PRIMARY | |||
|
159
Created by
admin on Fri Dec 15 19:02:46 GMT 2023 , Edited by admin on Fri Dec 15 19:02:46 GMT 2023
|
PRIMARY | |||
|
84621
Created by
admin on Fri Dec 15 19:02:46 GMT 2023 , Edited by admin on Fri Dec 15 19:02:46 GMT 2023
|
PRIMARY |